David R. Bauer
Lawyers
Filters
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Bloom Energy $632.5 million green convertible notes and capped call transactions
The 3% green convertible senior notes are due 2028
Schlumberger $1 billion senior notes offering
The investment-grade notes are due 2028 and 2033
GSK exclusive licensing agreement with Scynexis
We advised GSK on the transaction
Olema Pharmaceuticals $100 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Integral Ad Science $165.6 million secondary offering
The stock is listed on the Nasdaq Global Market
ACELYRIN $621 million IPO
The stock is listed on the Nasdaq Global Select Market
Ocado Group acquisition of 6 River Systems
We are advising Ocado Group on the transaction
Cellular Biomedicine Group CAR-T collaboration and license agreement with Janssen
We are advising Cellular Biomedicine Group on the transaction
IDEAYA Biosciences $201 million equity offering
The common stock is listed on the Nasdaq Global Select Market